277 related articles for article (PubMed ID: 20381266)
1. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
4. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
5. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
8. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
Chen AM; Li BQ; Farwell DG; Marsano J; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):756-62. PubMed ID: 20421143
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
Sher DJ; Balboni TA; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Tishler RB
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1405-11. PubMed ID: 21177045
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer.
Morganti AG; Mignogna S; Deodato F; Massaccesi M; Cilla S; Calista F; Serafini G; Digesú C; Macchia G; Picardi V; Caravatta L; Di Lullo L; Giglio G; Sallustio G; Piermattei A; Cellini N; Valentini V
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1073-80. PubMed ID: 20472342
[TBL] [Abstract][Full Text] [Related]
13. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
14. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
Turaka A; Li T; Sharma NK; Li L; Nicolaou N; Mehra R; Burtness B; Cohen RB; Lango MN; Horwitz EM; Ridge JA; Feigenberg SJ
Am J Clin Oncol; 2010 Dec; 33(6):599-603. PubMed ID: 21063195
[TBL] [Abstract][Full Text] [Related]
15. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
[TBL] [Abstract][Full Text] [Related]
16. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
18. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
Turaka A; Li T; Nicolaou N; Lango MN; Burtness B; Horwitz EM; Ridge JA; Feigenberg SJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):65-70. PubMed ID: 20385457
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control.
Daly ME; Le QT; Kozak MM; Maxim PG; Murphy JD; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Chang DT
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1412-22. PubMed ID: 20675073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
